11/14/2024
8:50 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G | |
11/14/2024
4:46 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
11/13/2024
8:01 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4/A | |
11/13/2024
8:02 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2024
8:04 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/06/2024
4:07 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/06/2024
7:20 AM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
|
11/05/2024
3:02 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:49 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/19/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/17/2024
3:42 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/11/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/11/2024
3:32 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
3:31 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:31 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:26 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:27 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:13 PM | Rhythm Pharmaceuticals (Subject)
TETRAULT LYNN A. (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
5:00 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFR14A | |
08/07/2024
5:03 AM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
08/06/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/30/2024
4:09 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/18/2024
4:59 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:30 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:37 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
3:34 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
4:00 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/10/2024
4:01 PM | Garfield Alastair (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B7 | |
07/10/2024
3:07 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
3:39 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:41 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:30 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:35 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:37 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/25/2024
3:38 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad) It’s here. This is the moment we’ve been waiting for.
The next 3-6 months in crypto will be absolutely life-changing for those who are prepared.
Why? Because altcoin prices are about to explode. >> Register for the Workshop Now |
06/25/2024
3:38 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:44 PM | MCGIRR DAVID W J (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:47 PM | Rhythm Pharmaceuticals (Issuer)
TETRAULT LYNN A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:38 PM | Arbuckle Stuart A (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:39 PM | GOOD JENNIFER L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:41 PM | Bedrosian Camille L (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:42 PM | JEAN CHRISTOPHE (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
8:43 PM | Mathers Edward T (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/17/2024
4:28 PM | Rhythm Pharmaceuticals (Filer)
| Form DEFA14A | |
06/17/2024
4:19 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/07/2024
3:43 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/07/2024
6:10 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
6:31 PM | NEW ENTERPRISE ASSOCIATES 13 LP (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/26/2024
3:13 PM | Rhythm Pharmaceuticals (Filer)
| Form ARS | |
04/17/2024
3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/16/2024
7:11 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
6:00 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/03/2024
7:00 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/03/2024
5:18 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D/A | |
04/01/2024
4:25 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/22/2024
3:55 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/21/2024
3:21 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024
4:51 PM | PERCEPTIVE ADVISORS LLC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13D | |
03/20/2024
3:41 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024
7:50 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:52 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:53 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:54 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:56 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/19/2024
7:57 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
3:58 PM | Rhythm Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
3:44 PM | Rhythm Pharmaceuticals (Filer)
| Form 424B5 | |
02/29/2024
3:46 PM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:05 PM | Rhythm Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/22/2024
6:01 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/21/2024
6:00 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:00 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:01 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:01 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:02 PM | German Christopher Paul (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:02 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
6:03 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/15/2024
5:14 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:45 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:46 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:47 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:49 PM | Mazabraud Yann (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:50 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
4:13 PM | Rhythm Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G | |
02/09/2024
3:19 PM | Rhythm Pharmaceuticals (Subject)
Shulman Joseph (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
What most folks don’t know about oil (BIG missed opportunity) (Ad) $1 Trillion…
That’s how much Big Tech is set to spend on AI investment in the coming months—according to Goldman Sachs.
This investment is driving an A.I. boom that’s being felt across many industries…
Including a specific group of energy tickers since A.I. data centers use a massive amount of power.
One of those tickers is CEG, up nearly 600% in the last 3 years…
Combined with the upcoming presidential election, we have the recipe for a major shakeup in the market.
You see, each time the U.S. elects a new president, one overlooked part of the energy sector tends to see a big move.
Fact is… this energy niche is BOOMING. And expects this underappreciated niche to continue rallying well into 2026. |
02/05/2024
5:53 PM | Cramer Pamela J. (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:53 PM | Meeker David P (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:54 PM | Rhythm Pharmaceuticals (Issuer)
Shulman Joseph (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:54 PM | Rhythm Pharmaceuticals (Issuer)
Smith Hunter C (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
5:55 PM | Lee Jennifer Kayden (Reporting)
Rhythm Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:34 PM | GOLDMAN SACHS GROUP INC (Filed by)
GOLDMAN SACHS GROUP INC (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/24/2024
8:46 AM | BlackRock Inc. (Filed by)
Rhythm Pharmaceuticals (Subject)
| Form SC 13G/A | |
01/23/2024
8:04 AM | Rhythm Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/04/2024
6:15 AM | Rhythm Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
